<DOC>
	<DOCNO>NCT02564848</DOCNO>
	<brief_summary>Eligible patient female age 70 old diagnosis clinical T1-2N0 ER+ invasive breast cancer . Patients undergo standard care lumpectomy without sentinel node biopsy follow radiation hormonal therapy . Sentinel node biopsy also consider standard care patient localize breast cancer . Treatment often influence whether result biopsy show cancer . However , biologic factor primary tumor become important determine treatment recommendation woman estrogen receptor positive breast cancer .</brief_summary>
	<brief_title>IIT2015-06-Chung : Safety Efficacy Omission Sentinel Node Biopsy Patients With Clinical T1-2 Estrogen-Positive Breast Cancer Over Age 70</brief_title>
	<detailed_description>The primary objective study determine whether omission sentinel node biopsy patient meet eligibility criterion result acceptable regional recurrence rate 4 year period . A regional recurrence define recurrence ipsilateral axillary node , supraclavicular node internal mammary node . Secondary objective study include determine disease-free survival overall survival patient meet eligibility criterion sentinel node biopsy omit surgical treatment . After surgery , patient receive standard care radiation hormonal therapy affect breast . She may also receive chemotherapy determine treat physician . A physical examination affect breast regional lymph node conduct every six month first two year follow yearly last 3 year follow . Imaging affect breast occur every 12 month surgery per standard care .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Female age 70 old Diagnosis clinical T12N0 ER+ invasive breast cancer determine treat physician plan undergo lumpectomy follow radiation hormonal therapy . Patients lymph node palpable suspicious find nodal tumorfree nodal core needle biopsy permit , biopsyproven nodal metastasis exclude . Patients diagnosis ductal lobular carcinoma situ Patients diagnosis inflammatory breast cancer Patients undergone neoadjuvant chemotherapy Patients plan mastectomy Patients absolute contraindication radiation therapy Patients contraindication hormonal therapy Patients contraindication radiation .</criteria>
	<gender>Female</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Clinical T1-2N0 ER+</keyword>
	<keyword>Invasive breast cancer</keyword>
</DOC>